Neuronal Mechanisms of Sensory Processing During General Anesthesia

NCT00434382 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 768

Last updated 2010-07-30

No results posted yet for this study

Summary

The ability of Mid Latency Auditory Evoked Potentials for a routine monitoring of sensory suppression should be evaluated during a wide spectrum of clinically common forms general anesthesia.

Conditions

  • General Anesthesia

Interventions

DRUG

Sevoflurane

DRUG

Isoflurane

DRUG

Desflurane

DRUG

Propofol

DRUG

Fentanyl

DRUG

Sufentanil

DRUG

Alfentanil

DRUG

Remifentanil

DEVICE

Midlatency auditory evoked potentials

Sponsors & Collaborators

  • CareFusion

    collaborator INDUSTRY
  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV
  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Michael AM Daunderer, M.D.,Ph.D. · Klinik fuer Anaesthesiologie, Ludwig-Maximilians-Universitaet Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2003-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00434382 on ClinicalTrials.gov